Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II study of sildenafil citrate in Waldenstrom's macroglobulinemia.

Trial Profile

Phase II study of sildenafil citrate in Waldenstrom's macroglobulinemia.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2011

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Waldenstrom's macroglobulinaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 20 Dec 2007 Status changed from in prgoress to discontinued.
    • 06 Oct 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top